rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Chad Cowan

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, Century Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
19
Buys
1
Sells
1
Bought
$49K
Sold
$2,731
Companies
1
Companies where not an officer
0
First trade
1 Oct 2024
Last trade
11 Jun 2026
Last filed
15 Jun 2026

Companies traded

Where they are an officer
IPSC Century TherapeuticsOfficer · Biotechnology · last 11 Jun 20261 buy · 1 sell

Activity over time

1 Nov 2025 – 1 Oct 2026
101Nov 25Feb 26May 26Jul 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
11 Jun 2026filed 15 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code F$802358 at $2.24filing
11 Jun 2026filed 15 Jun 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code F$802358 at $2.24filing
1 Apr 2026filed 3 Apr 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code F$2,9891,365 at $2.19filing
1 Apr 2026filed 3 Apr 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code F$2,9891,365 at $2.19filing
11 Mar 2026filed 13 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code F$3,9071,431 at $2.73filing
11 Mar 2026filed 13 Mar 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code F$3,9071,431 at $2.73filing
2 Feb 2026filed 4 Feb 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code A—135,000 at $0.00filing
2 Feb 2026filed 4 Feb 2026IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—265,000 at $0.00filing
2 Feb 2026filed 4 Feb 2026IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—265,000 at $0.00filing
2 Feb 2026filed 4 Feb 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code A—135,000 at $0.00filing
2 Jan 2026filed 6 Jan 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code F$1,6031,611 at $0.995filing
2 Jan 2026filed 6 Jan 2026IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code F$1,6111,611 at $1.00filing
22 Dec 2025filed 29 Dec 2025IPSC Century TherapeuticsBiotechnologySEC FORM 4 Bought$49K58,060 at $0.85filing
20 Nov 2025filed 24 Nov 2025IPSC Century TherapeuticsBiotechnologySEC FORM 4 Sold$2,7315,462 at $0.50filing
18 Sep 2025filed 22 Sep 2025IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code A—762,543 at $0.00filing
11 Mar 2025filed 12 Mar 2025IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—19,500 at $0.00filing
11 Mar 2025filed 12 Mar 2025IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code A—19,500 at $0.00filing
1 Oct 2024filed 3 Oct 2024IPSC Century Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—446,250 at $0.00filing
1 Oct 2024filed 3 Oct 2024IPSC Century TherapeuticsBiotechnologySEC FORM 4 Code A—74,376 at $0.00filing

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Douglas CarrSVP Finance & Operations · SVP Finance & Operations at Century Therapeutics, filing Form 4 there in the last year
Brent PfeiffenbergerPresident and CEO · President and CEO at Century Therapeutics, filing Form 4 there in the last year
Gregory RussottiOfficer · Officer at Century Therapeutics, filing Form 4 there in the last year
Joseph TruittDirector · Director at Century Therapeutics, filing Form 4 there in the last year
Alessandro RivaDirector · Director at Century Therapeutics, filing Form 4 there in the last year